Anorexigenic neuropeptides as anti-obesity and neuroprotective agents
Bioscience Reports · 2024
DOI: 10.1042/bsr20231385 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioscience Reports, 2024. Verfasst von Veronika Strnadová und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic. Hauptthemen laut MEDLINE: Neuroprotective Agents, Obesity, Neuropeptides, Anti-Obesity Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union - Next generation EU, Czech Academy of Sciences, Technologická Agentura České Republiky (Czech Technological Agency).
Abstract (Originalsprache)
Since 1975, the incidence of obesity has increased to epidemic proportions, and the number of patients with obesity has quadrupled. Obesity is a major risk factor for developing other serious diseases, such as type 2 diabetes mellitus, hypertension, and cardiovascular diseases. Recent epidemiologic studies have defined obesity as a risk factor for the development of neurodegenerative diseases, such as Alzheimer’s disease (AD) and other types of dementia. Despite all these serious comorbidities associated with obesity, there is still a lack of effective antiobesity treatment. Promising candidates for the treatment of obesity are anorexigenic neuropeptides, which are peptides produced by neurons in brain areas implicated in food intake regulation, such as the hypothalamus or the brainstem. These peptides efficiently reduce food intake and body weight. Moreover, because of the proven interconnection between obesity and the risk of developing AD, the potential neuroprotective effects of these two agents in animal models of neurodegeneration have been examined. The objective of this review was to explore anorexigenic neuropeptides produced and acting within the brain, emphasizing their potential not only for the treatment of obesity but also for the treatment of neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic.
- Department of Biochemistry and Molecular Biology, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
ORCID-Profile: Lenka Maletínská
Förderung
- European Union - Next generation EU
- Czech Academy of Sciences
- Technologická Agentura České Republiky (Czech Technological Agency)
- European Union – Next generation EU
Zitieren
APA
Strnadová, V., Pačesová, A., Charvát, V., Šmotková, Z., Železná, B., Kuneš, J., & Maletínská, L. (2024). Anorexigenic neuropeptides as anti-obesity and neuroprotective agents. Bioscience Reports. https://doi.org/10.1042/bsr20231385
Vancouver
Strnadová V, Pačesová A, Charvát V, Šmotková Z, Železná B, Kuneš J, et al. Anorexigenic neuropeptides as anti-obesity and neuroprotective agents. Bioscience Reports. 2024. doi:10.1042/bsr20231385
BibTeX
@article{Strnadov2024,
author = {Strnadová, Veronika and Pačesová, Andrea and Charvát, Vilém and Šmotková, Zuzana and Železná, Blanka and Kuneš, Jaroslav and Maletínská, Lenka},
title = {Anorexigenic neuropeptides as anti-obesity and neuroprotective agents},
journal = {Bioscience Reports},
year = {2024},
doi = {10.1042/bsr20231385}
}
EUVIMED